Search results
Regeneron shares rise on Evercore ISI Outperform rating By Investing.com
Investing.com· 1 day agoOn Monday, Evercore ISI initiated coverage on Regeneron (NASDAQ:REGN) Pharmaceuticals, Inc....
Qsemble Capital Management LP Purchases Shares of 239 Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
ETF DAILY NEWS· 20 hours agoQsemble Capital Management LP acquired a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the 4th quarter, according to its most ...
Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 10 Years - ...
Benzinga· 14 hours agoRegeneron Pharmaceuticals REGN has outperformed the market over the past 10 years by 2.01% on an annualized basis producing an average annual return of 12.78%. Currently, ...
Regeneron's cell medicines chief is crafting a new cell therapy 'secret sauce'
FierceBiotech· 6 days agoPhil Gregory’s new gig looks a whole lot like his old gig. It’s just that, under the umbrella of ...
Sanofi (SNY), Regeneron's Dupixent sBLA Gets FDA Priority Tag
Zacks via Yahoo Finance· 2 days agoSanofi (SNY) and Regeneron's (REGN) Dupixent is poised to be the first medicine for adolescents with...
Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) large institutional owners must be happy as stock...
Simply Wall St. via Yahoo Finance· 5 days agoKey Insights Institutions' substantial holdings in Regeneron Pharmaceuticals implies that they have...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Merit Financial Group LLC
ETF DAILY NEWS· 6 days agoMerit Financial Group LLC lessened its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 53.7% in the fourth quarter, according to its most ...
Regeneron, Sanofi Get Speedy FDA Review of Dupixent in Younger CRSwNP Group
Morningstar· 2 days agoRegeneron Pharmaceuticals and Sanofi have won Food and Drug Administration priority review of their application seeking expanded approval of their blockbuster anti-inflammatory ...
Regeneron gene therapy improves hearing in two children
BioPharma Dive via Yahoo Finance· 7 days agoDive Brief: A profoundly deaf baby who received Regeneron’s experimental gene therapy was able to...
...Review for Treatment of Adolescents with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP) - ...
Benzinga· 2 days agoRegeneron Pharmaceuticals, Inc. REGN and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics ...